Status:
RECRUITING
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Lead Sponsor:
University of Pittsburgh
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic mark...
Detailed Description
People who are diagnosed with idiopathic pulmonary fibrosis are asked to participate in this study. The subject must be treated at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Di...
Eligibility Criteria
Inclusion
- Patients who are 18 or older
- Diagnosis of Idiopathic Pulmonary Fibrosis
- Treated at the Simmons Center
Exclusion
- Other Lung Illness
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00373841
Start Date
October 1 2005
End Date
July 1 2030
Last Update
October 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michelle F MacPherson
Pittsburgh, Pennsylvania, United States, 15213